Results 261 to 270 of about 424,378 (382)

Microangiopathic Hemolytic Anemia and Cancer

, 1979
Karen H. Antman, Arthur T. Skarin, Robert J. Mayer, Hilary K. Hargreaves, George P. Canellos   +4 more
openalex   +1 more source

Congenital nonspherocytic hemolytic anemia with an unstable hexokinase variant [PDF]

, 1978
Philip G. Board, Robert C. Trueworthy, Joseph Smith, Kateri Moore   +3 more
openalex   +1 more source

Uncovering Glucose-6-Phosphate Isomerase (GPI) Deficiency in a Five-Year-Old With Hemolytic Anemia in Bahrain. [PDF]

Cureus
Busehail M, Qasim FN, Alasheeri FJ, Aloraibi A.   +3 more
europepmc   +1 more source

Gm Allotype Preference in Erythrocyte IgG Antibodies of Patients With Autoimmune Hemolytic Anemia [PDF]

, 1973
Stephen D. Litwin, S. Balaban, M. Elaine Eyster   +2 more
openalex   +1 more source

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 449-458, August 2025.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow, Marek Wardecki, Michael Storek, Nancy Wong   +3 more
wiley   +1 more source

Eosinophilic Granulomatous Polyangiitis with Autoimmune Hemolytic Anemia: A Case Report and Review of the Literature. [PDF]

J Asthma Allergy
Xie M, Ni R, Zhang J, Zhong M, Wang P.
europepmc   +1 more source

G-6-PD Long Prairie: a new glucose-6-phosphate dehydrogenase mutant exhibiting normal sensitivity to inhibition by NADPH and accompanied by nonspherocytic hemolytic anemia [PDF]

, 1977
GJ Johnson, ME Kaplan, Ernest Beutler
openalex   +1 more source

Flurbiprofen-Associated Hemolytic Anemia

American Journal of Therapeutics, 2019
Gulen M, Ünver Koluman, Başak, Avci A, Satar S   +3 more
openaire   +3 more sources

Real‐World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective Study

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Introduction Rituximab is used off‐label for treating cold agglutinin disease (CAD) in the United States; however, real‐world data on its use are limited. Methods This study examined (1) treatment patterns, (2) prespecified safety outcomes, and (3) changes in hemolytic markers post rituximab infusion (threshold change from baseline: hemoglobin
Caroline Piatek, Irina Murakhovskaya, Alia Karaouni, Gandarvaka Miles, Sylvie Bozzi, Carrie Heller, Jacqueline Lucia, Reena Patel, Brad Ward, Ronnie Yoo, Morie Gertz   +10 more
wiley   +1 more source

Retrospective Evaluation of Hematological Ratios in Dogs With Nonassociative Immune-Mediated Hemolytic Anemia: 206 Cases. [PDF]

J Vet Intern Med
Duclos AA, O'Sullivan L, McPhedran C, Hocker S, Le Boedec K, Blois S, Cuq B.   +6 more
europepmc   +1 more source